Centogene Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases. | Cellink CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products. | TwinStrand Biosciences TwinStrand Biosciences is a company that develops Duplex Sequencing technology aimed at DNA sequencing. | Biomeme Biomeme is a biotech company specializing in DNA diagnostics that develops mobile molecular testing platforms. | ||
Founding Date | Founding Date 2005 | Founding Date 2016 | Founding Date 2015 | Founding Date 2013 | Founding Date 2012 |
Type | Type Public | Type Subsidiary | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Rostock, DE HQ Wien, AT Berlin, DE Frankfurt Am Main, DE Hamburg, DE Greater Noida, IN Dubai, AE see more | Locations Göteborg, SE HQ Dardilly, FR Kyoto, JP Göteborg, SE Brighton, GB Blacksburg, US Boston, US | Locations Seattle, US HQ | Locations San Diego, US HQ | Locations Philadelphia, US HQ |
Employees | Employees 80823% increase | Employees 983% decrease | Employees 24 | Employees 3 | Employees 713% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) €48.5m (FY, 2023) | Revenue (est.) kr74.2m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods €29.1m (FY, 2023) | Cost of goods kr40.2m (FY, 2021) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €23.7m (FY, 2023) | Gross profit kr34.1m (FY, 2021) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income (€35.5m) (FY, 2023) | Net income (kr27.4m) (FY, 2021) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 29.6m | Total funding raised $ 4.1m | Total funding raised $ 23.2m | Total funding raised N/A | Total funding raised N/A |